Ayelet Waldman, author of "A Really Good Day," shares her transformative experience with microdosing and its positive effects on her life. Robin Carhart-Harris, head of psychedelic research at Imperial College London, discusses the neurological mechanisms behind psychedelics and their therapeutic potential. Christian Angermayer, an investor in psychedelic innovations, highlights the shift in mental health treatment perspectives. The conversation explores microdosing’s role in combating depression, the opioid crisis, and the evolving legal landscape surrounding psychedelics.
